Clinical impact of drug-eluting stents in an unselected population of diabetic patients.

Clinical Cardiology
Antonio J Domínguez FrancoEduardo De Teresa Galván

Abstract

Drug-eluting stents (DES) have been shown in randomized trials to reduce clinical events in diabetic patients. Our aim was to determine whether these clinical results are applicable in an unselected population of patients with non-insulin-dependent diabetes mellitus (NIDDM) and insulin-dependent diabetes mellitus (IDDM). We studied 440 consecutive patients (271 NIDDM and 169 IDDM) who underwent percutaneous coronary intervention, divided into 2 cohorts: Group A (1998-2000): 220 patients with bare metal stents, and Group B (2002-2004): 220 patients with drug-eluting stents. We analyzed major coronary adverse events (death, nonfatal acute myocardial infarction, and target lesion revascularization) over a mean follow-up of 18+/-15 months. Group B had more patients who were insulin-dependent (44.5 versus 32.3% p<0.001) or had hypertension (64.5 versus 54.1%; p=0.02), a lower left ventricular ejection fraction (53.89 versus 56.8%; p=0.04), more complex lesions (B2/C) (82.7 versus 62.3%; p<0.001), more treated lesions (1.40 versus 1.26; p<0.001), more stents implanted (1.69 versus 1.15; p<0.0001), and more patients treated with abciximab (76.8 versus 42.7%; p<0.0001). During the follow-up, Group B had fewer major adverse coronary eve...Continue Reading

References

Sep 19, 1998·Journal of the American College of Cardiology·A AbizaidM B Leon
Jan 16, 2004·The New England Journal of Medicine·Gregg W StoneUNKNOWN TAXUS-IV Investigators
Aug 18, 2005·The New England Journal of Medicine·Alban DibraUNKNOWN ISAR-DIABETES Study Investigators

❮ Previous
Next ❯

Citations

Aug 14, 2012·Journal of Interventional Cardiology·Fabrizio D'AscenzoImad Sheiban
Aug 2, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Sa'ar MinhaRan Kornowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

The New England Journal of Medicine
Bypass Angioplasty Revascularization Investigation (BARI) Investigators
The New England Journal of Medicine
P W SerruysArterial Revascularization Therapies Study Group
© 2022 Meta ULC. All rights reserved